万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型_老虎社区_美港股上老虎

万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型

美股速递03-20

万达生物制药近日公开敦促美国食品药品监督管理局采取实质性行动，加快医药研发领域从传统动物试验向更具人体相关性的替代方法转变。该公司指出，当前基于人类生物学的新型检测技术已展现出更精准预测药物反应的潜力，此举将有望重构药物安全评估体系，提升临床转化效率。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

暂无评论

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1106740354?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-03-20 04:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1106740354","market":"us","top_or_hot":-1,"title":"万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型","media":"美股速递","content":"<p>万达生物制药近日公开敦促美国食品药品监督管理局采取实质性行动，加快医药研发领域从传统动物试验向更具人体相关性的替代方法转变。该公司指出，当前基于人类生物学的新型检测技术已展现出更精准预测药物反应的潜力，此举将有望重构药物安全评估体系，提升临床转化效率。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型\n</h2>\n\n<h4 class=\"meta\">\n\n2026-03-20 04:37 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>万达生物制药近日公开敦促美国食品药品监督管理局采取实质性行动，加快医药研发领域从传统动物试验向更具人体相关性的替代方法转变。该公司指出，当前基于人类生物学的新型检测技术已展现出更精准预测药物反应的潜力，此举将有望重构药物安全评估体系，提升临床转化效率。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VNDA","symbol_name":"万达生物制药","start_time":0,"source_url":"","article_id":"1106740354","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1106740354","pubTimestamp":1773952632,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"万达生物制药近日公开敦促美国食品药品监督管理局采取实质性行动，加快医药研发领域从传统动物试验向更具人体相关性的替代方法转变。该公司指出，当前基于人类生物学的新型检测技术已展现出更精准预测药物反应的潜力，此举将有望重构药物安全评估体系，提升临床转化效率。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"VNDA":"万达生物制药","BK4139":"生物科技"},"translate_title":"Wanda Biopharmaceuticals calls on FDA to accelerate the transition from animal testing to human-related methods","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VNDA":1},"content_text":"万达生物制药近日公开敦促美国食品药品监督管理局采取实质性行动，加快医药研发领域从传统动物试验向更具人体相关性的替代方法转变。该公司指出，当前基于人类生物学的新型检测技术已展现出更精准预测药物反应的潜力，此举将有望重构药物安全评估体系，提升临床转化效率。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}